A 2-Part, Phase 2 Open-label and Crossover Study of Belumosudil for Treatment of Idiopathic Pulmonary Fibrosis
Clinical trial NCT02688647 · COMPLETED
Trial details
- NCT number
- NCT02688647
- Sponsor
- Kadmon Corporation, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-26
- Primary completion
- 2021-04-13
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.